| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
KARD (KARD) has 10 insiders with recent SEC Form 4 filings. KARD is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.79M | $314.04M | - | |
| 10% | 13.79M | $314.04M | - | |
| CEO | 5.67M | $128.99M | - | |
| Other | 79.6K | $1.81M | - | |
| CFO | 79.6K | $1.81M | - |
No transactions found
Try adjusting your filters or search criteria